financetom
Business
financetom
/
Business
/
Update: Aptiv Shares Plunge After Q3 Revenue Falls; 2024 Guidance Lowered
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Aptiv Shares Plunge After Q3 Revenue Falls; 2024 Guidance Lowered
Oct 31, 2024 10:03 AM

12:35 PM EDT, 10/31/2024 (MT Newswires) -- (Updates with the latest price movement in the headline and first paragraph.)

Aptiv ( APTV ) shares were down by more than 18% in recent Thursday trading after reporting a decline in Q3 revenue and lowering its the full-year outlook.

The company reported Q3 adjusted earnings of $1.83 per diluted share, up from $1.30 a year earlier.

Analysts polled by Capital IQ expected $1.66.

Revenue for the quarter ended Sept. 30 was $4.85 billion, down from $5.11 billion a year earlier.

Analysts surveyed by Capital IQ expected $5.11 billion.

Aptiv ( APTV ) now expects full-year 2024 adjusted EPS of $6.00 to $6.30, down from $6.15 to $6.45 previously. Analysts surveyed by Capital IQ expect $6.20.

The company lowered its 2024 revenue guidance to $19.60 billion to $19.90 billion from $20.10 billion to $20.40 billion. Capital IQ analysts expect $20.15 billion.

Price: 56.80, Change: -12.27, Percent Change: -17.76

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Loews' Q1 Earnings, Revenue Increase
Loews' Q1 Earnings, Revenue Increase
May 6, 2024
06:37 AM EDT, 05/06/2024 (MT Newswires) -- Loews ( L ) reported Q1 earnings Monday of $2.05 per diluted share, up from $1.61 a year earlier. Revenue for the quarter ended March 31 was $4.23 billion, compared with $3.78 billion a year earlier. Analysts' estimates were not readily available for comparison. Price: 79.49, Change: +3.09, Percent Change: +4.04 ...
MannKind Receives FDA Fast Track Designation for its Potential Lung Disease Treatment
MannKind Receives FDA Fast Track Designation for its Potential Lung Disease Treatment
May 6, 2024
06:38 AM EDT, 05/06/2024 (MT Newswires) -- MannKind ( MNKD ) said Monday it received US Food and Drug Administration fast track designation for clofazimine inhalation suspension for the treatment of nontuberculous mycobacterial lung disease. Fast-track designation eases the development and speeds up reviews of drugs treating serious conditions for which there are few if any treatments. The designation came...
Eastern Platinum Q4 Net Income More Than Doubles
Eastern Platinum Q4 Net Income More Than Doubles
May 6, 2024
06:34 AM EDT, 05/06/2024 (MT Newswires) -- Eastern Platinum ( ELRFF ) over the weekend reported a more than doubling of fourth-quarter net income on higher third-party chrome concentrate sales. The company reported fourth-quarter net income attributable to shareholders of US$3.3 million, or US$0.02 per share, up from US$1.4 million, or US$0.01 per share. Revenue climbed to US$30.5 million, a...
High Tide Opens Second Canna Cabana in Ajax, Ontario; Is 170th Store in Canada
High Tide Opens Second Canna Cabana in Ajax, Ontario; Is 170th Store in Canada
May 6, 2024
06:38 AM EDT, 05/06/2024 (MT Newswires) -- High Tide (HITI.V), a cannabis retailer, on Monday will open its second Canna Cabana retail cannabis store in Ajax, Ontario. Located at 1949 Ravenscroft Road, the store will sell recreational cannabis products and consumption accessories for adult use. The opening is High Tide's 170th Canna Cabana branded retail cannabis location in Canada and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved